Medscape www.medscape.com

References for:
Pituitary Gene Mutations and the Growth Hormone Pathway

[Semin Reprod Med 18(1):21-29, 2000. © 2000 Thieme Medical Publishers]

  1. Rimoin DL, Phillips JA III. Genetic disorders of the pituitary gland. In: Rimoin DL, Connor JM, Pyeritz RE, eds. Principles and Practice of Medical Genetics. 3rd ed. New York: Churchill Livingstone; 1997:1331-1364
  2. Phillips JA III. Inherited defects in growth hormone synthesis and action. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 6th ed. New York: McGraw-Hill; 1995:3023-3044
  3. Carel J-C, Tresca J-P, Letrait M, et al. Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: a population register-based study. J Clin Metab 1997;82:2117-2121
  4. Cacciari E, Zucchini S, Carla G, et al. Endocrine function and morphological findings in patients with disorders of the hypothalamo-pituitary area: a study with magnetic resonance. Arch Dis Child 1990;65:1199-1202
  5. Laron Z, Kelijman M, Pertzelan A, Keret R, Shoffner JM, Parks JS. Human growth hormone gene deletion without antibody formation or arrest during treatment: a new dis-ease entity? Isr J Med Sci 1985;21:999-1006
  6. Matsuda I, Hata A, Jinno Y, et al. Heterogeneous phenotypes of Japanese cases with a growth hormone gene deletion. Jpn J Hum Genet 1987;32:227-235
  7. Vnencak-Jones CL, Phillips JA III, Chen EY, Seeburg PH. Molecular basis of human growth hormone gene deletions. Proc Natl Acad Sci U S A1988;85:5615-5619
  8. Vnencak-Jones CL, Phillips JA III, De-fen W. Use of polymerase chain reaction in detection of growth hormone gene deletions. J Clin Endocrinol Metab 1990;70:1550-1553
  9. Mullis PE, Akinci A, Kanaka C, Eble A, Brook CGD. Prevalence of human growth hormone-1 gene deletions among patients with isolated growth hormone deficiency from different populations. Pediatr Res 1992;31:532-534
  10. Duquesnoy P, Amselem S, Gourmelen M, LeBouc Y, Goossens M. A frameshift mutation causing isolated growth hormone deficiency type 1A. Am J Hum Genet 1990;47:A110
  11. Cogan JD, Phillips JA III, Sakati N, Frisch H, Schober E, Milner RDG. Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. J Clin Endocrinol Metab 1993;76:1224-1228
  12. Cogan JD, Phillips JA III, Schenkman SS, Milner RDG, Sakati N. Familial growth hormone deficiency: a model of dominant and recessive mutations affecting a monomeric protein. J Clin Endocrinol Metab 1994;79:1261-1265
  13. Miller-Davis S, Phillips JA III, Milner RDG, Al-Ashwal A, Sakati NA, Summar ML. Detection of mutations in GH genes and transcripts by analysis of DNA from dried blood spots and mRNA from lymphoblastoid cells. Endocrine Society Program and Abstracts 333, 1993
  14. Abdul-Latif HD, Brown MR, Parks JS, et al. Mutation of intron 4 of the GH-1 gene causes GH deficiency. Endocrine Society Programs and Abstracts 470, 1995
  15. Igarashi Y, Ogawa M, Kamijo T, et al. Anew mutation causing inherited growth hormone deficiency: a compound heterozygote of a 6.7 kb deletion and two base deletion in the third exon of the GH-1 gene. Hum Mol Genet 1993;2: 1073-1074
  16. Cogan JD, Ramel B, Lehto M. A recurring dominant-negative mutation causes autosomal dominant growth hormone deficiency. J Clin Endocrinol Metab 1995;80:3591- 3595
  17. Phillips JA III, Cogan JD. Genetic basis of endocrine disease 6: molecular basis of familial human growth hormone deficiency. J Clin Endocrinol 1994;78:11-16
  18. Binder G, Ranke MB. Screening for growth hormone (GH) gene splice-site mutations in sporadic cases with severe isolated GH deficiency using ectopic transcript analysis. J Clin Endocrinol Metab 1995;80:1247-1252
  19. Cogan JD, Prince MA, Lekhakula S, et al. A novel mechanism of aberrant pre-mRNA splicing in humans. Hum Mol Genet 1997;6:909-912
  20. Wajnrajch MP, Gertner JM, Moshang T, Saenger P, Leibel RL. Isolated growth hormone (GH) deficiency, type II (IGHD II) caused by substitution of arginine by histidine in C-terminal portion of the GH molecule. Endocrine Society Program Abstracts P2-313, 1996
  21. Duriez B, Duquesnoy P, Dastot F, Bougneres P, Amselem S, Goossens M. An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency. FEBS Lett 1994;346:165-170
  22. Kowarski AA, Schneider JJ, Ben-Galim E, Weldon W, Daughaday WH. Growth failure with normal serum RIAGH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH. J Clin Endocrinol 1978;47:461-464
  23. Valenta LJ, Sigel MB, Lesniak MA, et al. Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers. N Engl J Med 1985;312:214-217
  24. Takahashi Y, Kaji H, Okimura Y, Goji K, Abe H, Chihara K. Brief report: short stature caused by a mutant growth hormone. N Engl J Med 1996;334:432-436
  25. Wajnrajch MP, Gertner JM, Harbison MD, Chua SC Jr, Leibel RL. Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet 1996;12:88-90
  26. Maheshwari H, Silverman BL, Dupuis J, Baumann G. Dwarfism of Sindh: a novel form of familial isolated GH deficiency linked to the locus for the GH releasing hormone receptor. Endocrine Society Program Abstracts OR46-2, 1996
  27. Salvatori, R, Gondo, RG, de Aguirar Oliveira MH, et al. Familial isolated growth hormone deficiency due to a novel mutation in the growth hormone-releasing hormone receptor. J Clin Endocrinol Metab 1999;84:917-923
  28. Woods KA, Fraser NC, Postel-Vinay MC, Savage MO, Clar AJL. Ahomozygous splice site mutation affecting the intra-cellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein. J Clin Endocrinol Metab 1996;81:1686-1690
  29. Berg MA, Argente J, Chernausek S, et al. Diverse growth hormone receptor gene mutations in Laron syndrome. Am J Hum Genet 1993;52:998-1005
  30. Lanes R, Plotnick LP, Spencer EM, et al. Dwarfism associated with normal serum growth hormone and increased bioassayable, receptorassayable, and immunoassayable somatomedin. J Clin Endocinol 1980;50:485
  31. Woods KA, Camacho-Hubner C, Savage MO, Clark AJL. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor 1 gene. N Engl J Med 1996;335:1363-1367
  32. Hermesz E, Mackem S, Mahon KA. Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo. Development 1996;122:41-52
  33. Dattani MT, Martinez-Barbera J-P, Thomas PQ, et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998;19:125-133
  34. Zhadanov AB, Bertuzzi S, Taira M, Dawid IB, Westphal H. Expression pattern of the murine LIM class homeobox gene Lhx3 in subsets of neural and neuroendocrine tissues. Dev Dyn 1995;202:354-364
  35. Netchine I, Sobrier M-L, Krude H, et al. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 2000;25:182-186
  36. Tatsumi K, Miyai K, Notomi T, et al. Cretinism with combined pituitary hormone deficiency caused by a mutation in the PIT1 gene. Nat Genet 1992;1:56-58
  37. Ohta K, Nobukuni Y, Mitsubuchi H, et al. Mutations in the Pit-1 gene in children with combined pituitary hormone deficiency. Biochem Biophys Res Commun 1992;189: 851-855
  38. Wit JM, Drayer NM, Jansen M, et al. Total deficiency of growth hormone and prolactin, and partial deficiency of thyroid stimulating hormone in two Dutch families: a new variant of hereditary pituitary deficiency. Horm Res 1989;32:170-177
  39. Pfaffle RW, DiMattia GE, Parks JS, et al. Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 1992;257:1118-1121
  40. Irie Y, Tatsumi K, Ogawa M, et al. A novel E250X mutation of the Pit-1 gene in a patient with combined pituitary hormone deficiency. Endocr J 1995;42:351-354
  41. Pelligrini-Bouiller I, Belicar P, Barlier A, et al. A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 1996;81:2790-2796
  42. Radovick S, Nation M, Du Y, Bergh LA, Weintraub BD, Wondisford FE. A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 1992;257:1115-1118
  43. Cohen LE, Wondisford FE, Salvantoni A, et al. Ahot spot in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. J Clin Endocrinol Metab 1995;80:679-684
  44. Sornson MW, Wu W, Dasen JS, et al. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 1996;384:327-333
  45. Wu W, Cogan JD, Pfaffle RW, et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 1998;18:147-149
  46. Cogan JD, Wu W, Phillips JA III, et al. The PROP1 2-bp deletion is a common cause of CPHD. J Clin Endocrinol Metab 1998;83:3346-3349
  47. Fofanova O, Takamura N, Kinoshita E, et al. Compound heterozygous deletion of the PROP-1 gene in children with combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998;83:2601-2604
  48. Lagerstrom-Fermer M, Sundvall M, Johnsen E, et al. X-linked recessive panhypopituitarism associated with a regional duplication in Xq25-q26. Am J Hum Genet 1997; 60:910-916
  49. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature 1989;340:692-696
  50. Shenker A. Activating mutations in G protein-coupled signaling pathways as a cause of endocrine disease. Growth Genet Horm 1996;12:33-38
  51. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991;12:325:1738-1740
  52. Ranke MB. Growth hormone therapy in children: when to stop? Horm Res 1995;43:122-125
  53. Rosen T, Johannsson G, Johansson JO, Bengtsson BA. Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. Horm Res 1995;43:93-99
  54. Strasburger CJ. Implications of investigating the structure-function relationship of human growth hormone in clinical diagnosis and therapy. Horm Res 1994;41:113-120
  55. Neely EK, Rosenfeld RG. Use and abuse of human growth hormone. Annu Rev Med 1994;45:407-420
  56. Wyatt DT, Mark D, Slyper A. Survey of growth hormone treatment practices by 251 pediatric endocrinologists. J Clin Endocrinol Metab 1995;80:3292-3297